Yuanyuan Li , Tianyu Wang , Yunbing Li , Chen Xu , Tianyi Wang , Lili Huang , Xiangkun Zeng , Guangfen Zhang , Chunli Li , Ning Dong
{"title":"Fitness cost of tet(A) type I variant-mediated tigecycline resistance in Klebsiella pneumoniae","authors":"Yuanyuan Li , Tianyu Wang , Yunbing Li , Chen Xu , Tianyi Wang , Lili Huang , Xiangkun Zeng , Guangfen Zhang , Chunli Li , Ning Dong","doi":"10.1016/j.jgar.2024.06.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The aim of the present study is to explore the impact of the <em>tet</em>(A) type I variant (<em>tet</em>A-v1) on its fitness effect in <em>Klebsiella pneumoniae</em>.</p></div><div><h3>Methods</h3><p>Clinical <em>K. pneumoniae</em> strains were utilized as parental strains to generate strains carrying only the plasmid vector (pBBR1MCS-5) or the <em>tet</em>A-v1 recombinant plasmid (p<em>tet</em>A-v1). Antimicrobial susceptibility testing was conducted to estimate the contribution of <em>tet</em>A-v1 to drug resistance. Plasmid stability was evaluated by serial passage over 10 consecutive days in the absence of tigecycline. Biological fitness was examined through growth curve analysis, <em>in vitro</em> competition assays and a neutropenic mouse thigh infection model.</p></div><div><h3>Results</h3><p>A 2–4-fold increase in tigecycline MIC was observed following the acquisition of <em>tet</em>A-v1. Without tigecycline treatment, the stability of p<em>tet</em>A-v1 plasmids has been decreasing since day 1. The p<em>tet</em>A-v1 plasmid in Kp89, Kp91, and Kp93 exhibited a decrease of about 20% compared to the pBBR1MCS-5 plasmid. The acquisition of the <em>tet</em>A-v1 gene could inhibit the growth ability of <em>K. pneumoniae</em> strains both <em>in vitro</em> and <em>in vivo. tet</em>A-v1 gene imposed a fitness cost in <em>K. pneumoniae</em>, particularly in the CRKP strain Kp51, with a W value of approximately 0.56.</p></div><div><h3>Conclusion</h3><p>The presence of <em>tet</em>A-v1 is associated with a significant fitness cost in <em>K. pneumoniae</em> in the absence of tigecycline, both <em>in vitro</em> and <em>in vivo</em>.</p></div>","PeriodicalId":15936,"journal":{"name":"Journal of global antimicrobial resistance","volume":"38 ","pages":"Pages 158-162"},"PeriodicalIF":3.7000,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2213716524001127/pdfft?md5=9704661f616749c4b4ac6f959c89237e&pid=1-s2.0-S2213716524001127-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of global antimicrobial resistance","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213716524001127","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
The aim of the present study is to explore the impact of the tet(A) type I variant (tetA-v1) on its fitness effect in Klebsiella pneumoniae.
Methods
Clinical K. pneumoniae strains were utilized as parental strains to generate strains carrying only the plasmid vector (pBBR1MCS-5) or the tetA-v1 recombinant plasmid (ptetA-v1). Antimicrobial susceptibility testing was conducted to estimate the contribution of tetA-v1 to drug resistance. Plasmid stability was evaluated by serial passage over 10 consecutive days in the absence of tigecycline. Biological fitness was examined through growth curve analysis, in vitro competition assays and a neutropenic mouse thigh infection model.
Results
A 2–4-fold increase in tigecycline MIC was observed following the acquisition of tetA-v1. Without tigecycline treatment, the stability of ptetA-v1 plasmids has been decreasing since day 1. The ptetA-v1 plasmid in Kp89, Kp91, and Kp93 exhibited a decrease of about 20% compared to the pBBR1MCS-5 plasmid. The acquisition of the tetA-v1 gene could inhibit the growth ability of K. pneumoniae strains both in vitro and in vivo. tetA-v1 gene imposed a fitness cost in K. pneumoniae, particularly in the CRKP strain Kp51, with a W value of approximately 0.56.
Conclusion
The presence of tetA-v1 is associated with a significant fitness cost in K. pneumoniae in the absence of tigecycline, both in vitro and in vivo.
期刊介绍:
The Journal of Global Antimicrobial Resistance (JGAR) is a quarterly online journal run by an international Editorial Board that focuses on the global spread of antibiotic-resistant microbes.
JGAR is a dedicated journal for all professionals working in research, health care, the environment and animal infection control, aiming to track the resistance threat worldwide and provides a single voice devoted to antimicrobial resistance (AMR).
Featuring peer-reviewed and up to date research articles, reviews, short notes and hot topics JGAR covers the key topics related to antibacterial, antiviral, antifungal and antiparasitic resistance.